The way you think, the way you behave, the way you eat, can influence your life by 30 to 50 years.

-Deepak Chopra

 

PNA Spotlight: Dr. Manish Aghi

This month the PNA Spotlight focuses on Dr. Manish K. Aghi.Dr. Manish Aghi is a neurosurgeon specializing in brain tumors at UCSF Medical Center. He cares for adult patients with a wide range of conditions, including astrocytomas and anaplastic astrocytomas, oligodendrogliomas, glioblastomas, meningiomas and pituitary adenomas. As principal investigator at the UCSF Brain Tumor Research Center, his interests include glioblastoma angiogenesis, mechanisms of glioblastoma resistance to anti-angiogenic therapy and experimental glioblastoma therapies such as cancer-killing viruses.
Professor Aghi earned his medical degree and a doctoral degree in neurosciences from Harvard Medical School. He completed a residency in neurosurgery at Massachusetts General Hospital. He is a member of the Society for Neuro-Oncology, American Association of Neurological Surgeons, Congress of Neurological Surgeons and Pituitary Network Association. Among his honors are the Preuss and Mahaley awards from the American Association of Neurological Surgeons, and the Ronald L. Bittner Award, Synthes Skull Base Award and Integra Foundation Award from the Congress of Neurological Surgeons.
His answers follow.

PNA Medical Corner: Pituitary Centers of Excellence

This month the PNA Medical Corner focuses on an article co-authored by several members and colleagues of the PNA: Drs. Chanson, Kaiser, Laws, van der Lely, and Melmed. It addresses a topic that PNA has sought to promote for decades: the designation of Pituitary Centers of Excellence, where patients can get highly specialized care

Link: https://pubmed.ncbi.nlm.nih.gov/37640885/

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

Featured News and Updates

The FDA has approved NGENLA (somatrogon-ghla)

The FDA has approved NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older who have growth failure due to an inadequate secretion of endogenous growth hormone.

See the Press Release here>

News Articles July 2026

Infant diagnosed with pituitary tumor

Doctors in the U.K. diagnosed a 4-month-old baby boy with a pituitary tumor and performed surgery to remove it. Read more: https://uk.news.yahoo.com/bradford-baby-diagnosed-brain-tumour-020000577.html

Pituitary journey: Soccer superstar Lionel Messi

A doctor in the U.K. well-known for his internet explainer videos explains on the case of soccer star Lionel Messi, who was diagnosed with growth hormone deficiency as a child and underwent years of growth hormone injections. His family paid for the medical care at first but then Team Barcelona agreed to cover the cost of his treatment in Spain.  See the YouTube video here: https://www.youtube.com/watch?v=Liovxj7D0H4

Pituitary journey: from patient to future neurosurgeon

An article on The Good Things Guy website looks at the pituitary journey of Cadi de Jager, a 19-year-old woman in South Africa who was diagnosed at age nine with a Rathke’s Cleft cyst. She underwent two surgeries and is now in college with the goal of becoming a pediatric neurosurgeon. Read more: https://www.goodthingsguy.com/cadi-de-jager-conquered-brain-tumour/

Sprained ankle leads to Cushing’s diagnosis

A teen in Brazil with a sprained ankle went to the ER – where alert doctors decided to test him for Cushing’s disease after hearing about his sudden weight gain, headaches and high blood pressure. Read more:  https://en.clickpetroleoegas.com.br/teens-weight-gain-and-cushings-disease-revealed-by-ankle-injury-doctors-discover-tiny-pituitary-tumor-in-113-kilo-brazilian-adolescent-vacs75/#goog_rewarded

Research Articles

Research Articles July 2026

Pituitary tumors

Pituitary adenoma-associated with Schopf-Schulz-Passarge syndrome.

Brady RT, Allinson K, René C.BMJ Case Rep. 2026 Jun 26;19(6):e267144. doi: 10.1136/bcr-2025-267144.

 

Immune and clinicopathological features of molecularly defined prolactinoma subtypes.

Wang DP, Liu YT, Dai YT, Chen S, Cheng YJ, Lin SJ, Zhang Y, Xue L, Xie J, Wu ZB.J Neurosurg. 2026 Jun 26:1-11. doi: 10.3171/2026.1.JNS251768. Online ahead of print.


Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors.

Yang Z, Liu Y, Wu D, Xu B, Zeng S, Zhang W.Int J Endocrinol. 2026 Jun 24;2026:3784550. doi: 10.1155/ije/3784550. eCollection 2026.


An Explainable Multi-Scale Deep Learning Framework for Multi-Class Brain MRI Classification.

Alshammari HH, Mahmood MA.Diagnostics (Basel). 2026 Jun 10;16(12):1791. doi: 10.3390/diagnostics16121791.

 

Clinical Features and Key Prognostic Indicators of Growth Hormone-Secreting Pituitary Adenomas: A Retrospective Study of 344 Cases.

Zhang Y, Mi Z, Wu H, Ma X, Xi L, Yang Z, Liu P.Curr Oncol. 2026 May 27;33(6):310. doi: 10.3390/curroncol33060310.

 

Pituitary Tumors in Maxillofacial Radiology and Daily Practice: A Scoping Review.

Stucki L, Mauer U, Kildal D, Rózsa NK, Geibel MA.Dent J (Basel). 2026 Jun 15;14(6):368. doi: 10.3390/dj14060368.

 

Radiomics for Preoperative Assessment of Pituitary Adenoma Consistency with T2-Weighted MRI: A Multicenter Study.

Agosti E, Cuocolo R, Mangili M, Rampinelli V, Veiceschi P, Cappelletti M, Panciani PP, Piazza A, Bove I, Solari D, Cavallo LM, Locatelli D, Doglietto F, Fiorindi A, Fontanella MM, Ugga L.J Neurol Surg B Skull Base. 2025 Jun 4;87(3):314-321. doi: 10.1055/a-2607-0735. eCollection 2026 Jun.

 

Acromegaly

Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.

Gadelha MR, Gordon MB, Doknic M, Mezősi E, Tóth M, Randeva H, Boguszewski CL, Davidson C, Casagrande A, Jochelson T, Krasner A.J Clin Endocrinol Metab. 2026 Jun 26:dgag254. doi: 10.1210/clinem/dgag254. Online ahead of print.

 

Cushing’s

Twenty years of neurosurgical experience with Cushing’s disease: surgical-strategies, endocrine outcomes and remission predictors in 346 patients.

Honegger J, Grimm F, Gött H, Nasi-Kordhishti I.Eur J Endocrinol. 2026 Jun 26:lvag115. doi: 10.1093/ejendo/lvag115. Online ahead of print.


Catheterization of the petrosal sinus: possible advantage of desmopressin stimulation in Cushing disease.

Garmes HM, Siqueira SC, Daniel KB, Trentin MBF, Fujiwara MT, Schinoll C, Fabbro MD, Rogerio F, Deus-Silva L, Reis F.Arch Endocrinol Metab. 2026 Jun 25;70(4):e260064. doi: 10.20945/2359-4292-2026-0064.

 

Pituitary apoplexy

Activated Macrophages Promote TNF-alpha-Associated Tumor Cell Necroptosis in Pituitary Apoplexy Through the PIEZO1-NFATC2/REL Axis.

Li X, Zhou L, Lei Z, Li S, Wang Q, Zhao H, Xu L, Chen J, Wan X, Huang Y, Lei T.Int J Mol Sci. 2026 Jun 22;27(12):5635. doi: 10.3390/ijms27125635.

 

Pituitary cancer

Beyond the Usual: Breast, Pituitary and Gastric Metastases from Clear Cell Renal Cell Carcinomas-A Case Series with Review of Literature.

Wong YP, Khairuddin NL, Thanabalan J, Tan GC.Diagnostics (Basel). 2026 Jun 9;16(12):1773. doi: 10.3390/diagnostics16121773.

 

Pituitary Metastasis in Lung Cancer Patients: Case Series and Review of the Literature.

Ntouraki S, Roumpou A, Asimakopoulou A, Gkiozos I, Sarropoulou F, Mani M, Marioli A, Bouklas D, Syrigos K, Peppa M.Curr Oncol. 2026 Jun 16;33(6):362. doi: 10.3390/curroncol33060362.

 

Hormonal Health

Salivary Cortisol Response After Ropivacaine-Dexamethasone Administration: A Randomized Clinical Trial.

Stojanović SM, Burić NB, Kostić MS, Burić KN, Stojković BB, Spasić MS, Tijanić M, Trajković M, Jovanović R, Petrović MS.Pharmaceuticals (Basel). 2026 Jun 12;19(6):930. doi: 10.3390/ph19060930.

 

The Global Decline in Sperm Count and Testosterone Levels: Trends, Mechanisms, and Environmental Drivers.

La Vignera S, Condorelli RA.Antioxidants (Basel). 2026 Jun 22;15(6):778. doi: 10.3390/antiox15060778.

 

Microplastics as trojan horses: A new perspective on bisphenol toxicity in male infertility and assisted reproduction.

Marraschi GK, Vitale OG, Kassuya CAL, Jorge BC, Arena AC.Reprod Toxicol. 2026 Jun 25:109298. doi: 10.1016/j.reprotox.2026.109298. Online ahead of print.

Copyright © 2024 Pituitary Network Association All rights reserved.

Disclaimer: PNA does not engage in the practice of medicine. It is not a medical authority, nor does it claim to have medical expertise. In all cases, PNA recommends that you consult your own physician regarding any course of treatment or medication.

Our mailing address is:
Pituitary Network Association
P.O. Box 1958
Thousand Oaks, CA 91358
(805) 499-9973 Phone - (805) 480-0633 Fax
Email [email protected]

You are receiving this Newsletter because you have shown interest in receiving information about our activities.

If you do not want to receive any more emails from PNA, Unsubscribe.